Barry Ladizinski

Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis

Andrew Blauvelt, Henrique D. Teixeira, Eric L. Simpson et al. · JAMA Dermatology · 2021 · 451 citations · Full text

Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial

Kristian Reich, Henrique D. Teixeira, Marjolein de Bruin‐Weller et al. · The Lancet · 2021 · 366 citations

Atopic Dermatitis, Medicine, Moderate-to-severe Atopic Dermatitis +9

Complications Associated With Use of Levamisole-Contaminated Cocaine: An Emerging Public Health Challenge

Kachiu C. Lee, Barry Ladizinski, Daniel G. Federman · Mayo Clinic Proceedings · 2012 · 153 citations · Full text

Substance Abuse, Substance Use, Health Sciences +10

Upadacitinib plus topical corticosteroids in atopic dermatitis: Week 52 AD Up study results

Jonathan I. Silverberg, Marjolein de Bruin‐Weller, Thomas Bieber et al. · Journal of Allergy and Clinical Immunology · 2021 · 119 citations · Full text

Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies

Emma Guttman‐Yassky, Jacob P. Thyssen, Jonathan I. Silverberg et al. · Journal of Allergy and Clinical Immunology · 2022 · 56 citations · Full text